Steven B. Deitelzweig - Pfizer, Inc | 人才画像

基本信息

浏览量：57

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 191 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Effectiveness and Safety in Non-Valvular Atrial Fibrillation Patients Switching from Warfarin to Direct Oral Anticoagulants in US Healthcare Claims

Gregory Y. H. Lip,Virginia Noxon,Amiee Kang,Xuemei Luo,Nipun Atreja,Stella Han,Dong Cheng,Jenny Jiang, Lisa Abramovitz,Steven Deitelzweig

JOURNAL OF THROMBOSIS AND THROMBOLYSISno. 6 (2024): 1092-1102

引用0浏览0WOS引用

Clinical Impact of Switching or Continuation of Apixaban or Rivaroxaban among Patients with Non-Valvular Atrial Fibrillation

Steven Deitelzweig,Amiee Kang,Jenny Jiang,Chuan Gao,Xuemei Luo,Nipun Atreja,Stella Han,Dong Cheng, Saarusri R. Loganathan,Gregory Y. H. Lip

JOURNAL OF CLINICAL MEDICINEno. 4 (2024)

引用0浏览0WOS引用

EVALUATION OF EFFECTIVENESS AND SAFETY OUTCOMES AMONG MEDICARE PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION WHO SWITCHED FROM WARFARIN TO DIRECT ORAL ANTICOAGULANTS

Nipun Atreja,Virginia Noxon,Amiee Kang,Dionne Hines,Jenny Jiang,Melissa Hagan,Dong Cheng, Lisa Abramovitz, Jason Maynard,Steven Bruce Deitelzweig

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGYno. 13 (2024): 1242-1242

引用0浏览0引用

Journey to Anticoagulant Access Following Payer Rejection of Apixaban

Steven Deitelzweig, Lin Xie,Emi Terasawa, David Weber Hood,Matthew Cato,Nipun Atreja,Amiee Kang,Dionne M. Hines

AMERICAN JOURNAL OF MANAGED CARE（2023）

引用0浏览0WOS引用

Clinical Impact of Switching or Continuation of Apixaban or Rivaroxaban among Patients with Non-Valvular Atrial Fibrillation

S. Deitelzweig,A. Kang,J. Jiang,C. Gao,X. Luo,N. Atreja,S. Han,D. Cheng,G. Lip

EUROPEAN HEART JOURNAL (2023)

引用0浏览0引用

Delaying Clinical Events among Patients with Non-Valvular Atrial Fibrillation Treated with Oral Anticoagulants: Insights from the ARISTOPHANES Study

Steven Deitelzweig,Allison Keshishian,Amiee Kang,Aaron Jenkins,Nipun Atreja,Patricia Schuler,Jenny Jiang,Huseyin Yuce,Xiaoxi Sun,Gregory Y. H. Lip

European journal of internal medicine（2023）

引用1浏览0WOS引用

Payer Formulary Exclusions of Apixaban: How Patients Respond and Potential Implications

Steven Deitelzweig,Emi Terasawa,Amiee Kang,Nipun Atreja,Dionne M. Hines,Ahmed Noman,Xuemei Luo

Current Medical Research and Opinion（2023）

引用2浏览0WOS引用

Thrombotic and Bleeding Events, Mortality, and Anticoagulant Use among 546,656 Hospitalized Patients with COVID-19 in the United States: a Retrospective Cohort Study

Deitelzweig Steve,Luo Xuemei,Nguyen Jennifer L.,Malhotra Deepa,Emir Birol,Russ Cristina, Li Xiaoyan,Lee Theodore C.,Ferri Mauricio,Wiederkehr Danny,Reimbaeva Maya,Barnes Geoffrey D.,Piazza Gregory

Journal of Thrombosis and Thrombolysis（2022）

引用9浏览0WOS引用

Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study (vol 53, pg 766, 2022)

Steve Deitelzweig, Xuemei Luo,Jennifer L. Nguyen,Deepa Malhotra,Birol Emir,Cristina Russ, Xiaoyan Li,Theodore C. Lee,Mauricio Ferri,Danny Wiederkehr,Maya Reimbaeva,Geoffrey D. Barnes,Gregory Piazza

JOURNAL OF THROMBOSIS AND THROMBOLYSISno. 4 (2022)

引用0浏览0引用

Risk Levels and Adverse Clinical Outcomes among Patients with Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants

Gregory Y. H. Lip,Richard R. Murphy,Farhad Sahiar, Timothy J. Ingall,Amol D. Dhamane,Mauricio Ferri,Patrick Hlavacek,Madison T. Preib,Allison Keshishian,Cristina Russ,Lisa Rosenblatt,Huseyin Yuce,Steven Deitelzweig

JAMA Network Open（2022）

引用3浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn